How mom's hemoglobin affects birth outcomes
Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.
This study looks at how different levels of hemoglobin and hematocrit in the mother's blood during pregnancy can affect the health of both mom and baby around the time of delivery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and between 28 and 42 weeks along.
- You are carrying only one baby.
- You are between 18 and 40 years old.
- You are willing to take part and give your permission.
- You do not have anemia caused by something other than low iron.
- You have not had heavy bleeding before delivery, a condition where the placenta grows into the womb muscle, or a baby with a major birth defect.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a mother's low iron (with or without anemia) affects her baby's iron levels at birth. It aims to help understand how to better protect both mothers and newborns.
This trial looks at how a mother’s iron levels during pregnancy might affect her child’s health. It aims to learn more about the link, which could help improve care for both.
This study tests whether giving regular blood transfusions during early pregnancy can help prevent complications for women with sickle cell disease. If you are between 6 and 20 weeks pregnant, you may join to see if this treatment improves outcomes.
This trial tests a treatment for iron deficiency anemia in pregnant women between 24 and 32 weeks. It aims to see if managing anemia improves health for both mother and baby.
This study compares two standard care methods for women after a normal vaginal delivery to see which one leads to better recovery. It may help improve your postpartum care and health.
This trial studies how hemoglobin (an oxygen-carrying protein in blood) is checked during pregnancy. It may help improve or confirm the best way to monitor blood health in pregnant patients.
Hear when a new Hemoglobin and Hematocrit Values on Perinatal Outcome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.